
Glenmark Pharmaceuticals launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose…














